Abstract

Robotic Process Automation (RPA) is a technological revolution in the offing and is aimed at taking up the mundane and repetitive tasks from people’s daily workload. It throws up a new vista of research to the research community and lot many types of research are going on in this domain. It is not Robotics but is different technology altogether. RPA is a recent and fast-growing sub-domain of Robotics. The healthcare and pharmaceutics domain generate a lot of data or we may call it medical big data, and it is all the more pertinent to analyze & evaluate such data coming from varied sources. New drug discovery, drug formulation process, drug delivery mechanisms or in-patient and out-patient activities are some of the key processes in the Healthcare and Pharmaceutical industries generating a tremendous amount of data. Therefore, data science and RPA provides handy tools to work with such huge data volumes. In this paper, the authors highlight the key aspects of RPA and review its usage in the all-important healthcare and pharmaceutics domain. RPA is proving to be the technology of future and its goal is to provide a sustainable solution that reduces costs and delivery time, improves quality, speed and operational efficiency of a business process. The application of Machine Learning (ML) technologies in the healthcare domain are proving to be beneficial and effective in gaining new insights. The author also proposes a generic RPA/ML-based framework to ensure the standardization and quality of Bhasma – an end product obtained after multiple activities in the traditional Indian System of Medicine – Ayurveda.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.